Navarro A, Costa R, Rodriguez-Carballeira M, Yun S, Lapuente A, Barrera A, Acosta E, Viñas C, Heredia J L, Almagro P
Servicio de Neumología, Hospital Universitario Mutua de Terrassa, Tarrasa, España.
Servicio de Medicina Interna, Hospital Universitario Mutua de Terrassa, Tarrasa, España.
Rev Clin Esp (Barc). 2015 Nov;215(8):431-8. doi: 10.1016/j.rce.2015.06.004. Epub 2015 Jul 13.
To validate the CODEX index in outpatients with advanced chronic obstructive pulmonary disease (COPD).
We studied all patients with COPD treated in a chronic respiratory disease unit. We calculated the BODEX and CODEX indices and their relationship with mortality, hospitalisations or both and performed an analysis by number of events (mortality and/or readmissions), using the Cox proportional hazards analysis.
We included 80 patients (90% men) with a mean age of 73.4 years. The mean follow-up was 656 days, with an interquartile range (25-75%) of 417-642 days. Seventeen patients died (21%) and 57 (71.3%) required hospitalisation for COPD. The CODEX index was significantly related to mortality (P<.008; HR: 1.56; 95% CI: 1.1-2.15), hospitalisations (P<.01; HR: 1.35; 95% CI: 1.13-1.62) and the combined variable (P<.03; HR: 1.27; 95% CI: 1.1-1.5). The BODEX index was not associated with mortality (P=.17) but was associated with hospitalisation (P<.001; HR: 1.4; 95% CI: 1.15-1.73) and the combined variable (P<.03; HR: 1.2; 95% CI: 1.02-1.34). There were 187 events during follow-up. Both the CODEX (P<.001; HR: 1.17; 95% CI: 1.1-1.27) and BODEX (P<.02; HR: 1.12; 95% CI: 1.02-1.23) indices were related to the number of events. However, after adjusting for the interaction between the 2 indices, only the CODEX index maintained statistical significance for the combined variable for patients (P<.03) and in the analysis by number of events (P<.001).
Both the CODEX and BODEX indices are useful for predicting hospitalisations, although the prognostic ability of the CODEX index is greater than that of the BODEX index, both for mortality and hospitalisations.
验证适用于晚期慢性阻塞性肺疾病(COPD)门诊患者的CODEX指数。
我们研究了在慢性呼吸疾病科接受治疗的所有COPD患者。我们计算了BODEX和CODEX指数及其与死亡率、住院率或两者的关系,并使用Cox比例风险分析按事件数量(死亡率和/或再入院率)进行分析。
我们纳入了80例患者(90%为男性),平均年龄73.4岁。平均随访时间为656天,四分位间距(25%-75%)为417-642天。17例患者死亡(21%),57例(71.3%)因COPD需要住院治疗。CODEX指数与死亡率(P<0.008;风险比:1.56;95%置信区间:1.1-2.15)、住院率(P<0.01;风险比:1.35;95%置信区间:1.13-1.62)以及综合变量(P<0.03;风险比:1.27;95%置信区间:1.1-1.5)显著相关。BODEX指数与死亡率无关(P=0.17),但与住院率相关(P<0.001;风险比:1.4;95%置信区间:1.15-1.73)以及综合变量相关(P<0.03;风险比:1.2;95%置信区间:1.02-1.34)。随访期间共有187个事件。CODEX指数(P<0.001;风险比:1.17;95%置信区间:1.1-1.27)和BODEX指数(P<0.02;风险比:1.12;95%置信区间:1.02-1.23)均与事件数量相关。然而,在对两个指数之间的相互作用进行校正后,仅CODEX指数在患者综合变量方面(P<0.03)以及按事件数量分析时(P<0.001)保持统计学显著性。
CODEX指数和BODEX指数均有助于预测住院情况,尽管在死亡率和住院率方面,CODEX指数的预后能力均强于BODEX指数。